12Part 2Develo
pment
of
Depres
sion
L E A R N I N G O U TC O M E S
levels of schizophrenia
Psychosis
Drugs, cocaine etc
Stigma
Interdisciplinary team and care issue
Continue care
Share experiences from placement, learning
points
GLIAL CELLS
Their main functions are to provide support and insulation to axons in the central nervous
system of some vertebrates, equivalent to the function performed by Schwann cells in
the peripheral nervous system.
The central nervous system has limited ability to fix its damaged nerves, in
Remarkably, almost 90% of cells in the CNS are not even neurons. Rather
they are glial cells, which play an important role in supporting neurons both
physically and metabolically.
GANGLIA
IN
CNS
In the central nervous system, a collection of neuron cell bodies is called a nucleus. In
the peripheral nervous system, a collection of neuron cell bodies is called
a ganglion (plural: ganglia). The one exception to this rule that you may have encountered
DOPAMINE
AND
SCHIZOPHRENIA
The D1 and D5 receptors are members of the D1-like family of dopamine receptors,
whereas the D2, D3 and D4 receptors are members of the D2-like family.
Activation of D1-like family receptors is coupled to the G protein Gs, which subsequently
activates adenylyl cyclase, increasing the intracellular concentration of thesecond
messenger cyclic adenosine monophosphate (cAMP).
D2-like family Activation of D2-like family receptors is coupled to the G protein Gi,
which directly inhibits the formation of cAMP by inhibiting the enzyme adenylyl
cyclase.
PSYCHOSIS
WHAT IS PSYCHOSIS?
Young people often worry that they may be going mad' when they are feeling
stressed, confused or very upset. In fact, worries like this are rarely a sign of
mental illness. Psychosis is when your thoughts are so disturbed that you lose
touch with reality. This type of problem can be severe and distressing.
If the psychosis is related to drug use or an underlying physical illness, you may
need specic help and treatment to manage this.
It's also possible to experience psychosis after drinking large amounts of alcohol
or if you're high on drugs.
Drugs known to trigger psychotic episodes include:
cocaine
amphetamine (speed)
methamphetamine (crystal meth)
mephedrone (MCAT or miaow)
MDMA (ecstasy)
cannabis
LSD (acid)
psilocybins (magic mushrooms)
ketamine
DRUGS
Drug
Subgroup:
Specific drugs:
Examples:
Benzodiazepin
es
Benzodiazepin
e agonists
Barbiturates
Diazepam (Valium),
clonazepam (Klonopin),
lorazepam (Ativan),
temazepam (Restoril),
flunitrazepam
(Rohypnol), triazolam
(Halcion), alprazolam
(Xanax)
Zolpidem (Ambien),
eszopiclone (Lunesta),
zopiclone, zaleplon
(Sonata)
Sedatives
Mechanism:
Major
effects:
Side effects:
Any medical
use:
Agonist at
benzodiazepin
e site on the
GABA-A
receptor
Calm,
relaxed
muscles,
sleepy
Drowsiness,
falls, impaired
coordination,
impaired
memory,
dizziness
Anxiety,
insomnia,
epilepsy, many
other diseases
Same as above
Mainly just
sleepy,
sometimes
hallucination
s and sleeplike states
Calm,
euphoric,
sleepy
Same as
benzodiazepines
Insomnia
Same as
benzodiazepines
, plus breathing
suppressed,
terrible
withdrawal,
death
Same as
benzodiazepines
, plus nausea,
vomiting,
breathing
suppressed,
terrible
withdrawal
(including
psychosis and
seizures), brain
damage, various
diseases, death
Epilepsy, other
diseases in the
past and more
rarely today
Same as
benzodiazepines
, plus nausea,
vomiting,
breathing
suppressed,
psychosis,
seizures, death
Narcolepsy
(improves
cataplexy, not
simply a sleep
aid)
Phenobarbital,
pentobarbital, thiopental
(sodium pentothal,
sodium amytal),
secobarbital
Agonist at
barbiturate site
on the GABAA receptor
Alcohol
Opens BK
potassium
channels
(hyperpolarizi
ng neurons),
closes SK
potassium
channels in
reward center
of brain
(causing DA
release),
probably other
effects
Agonist at
GHB receptor
(may
desensitize it
or inhibit
GABA),
agonist at
GABA-B
receptor
Calm,
euphoric,
loss of
inhibitions
(facilitates
socializing,
talking,
singing,
sex), relaxed
Euphoric,
energetic,
sleepy, calm
(mix of
stimulant
and sedative
effects)
Alcohol
withdrawal
Amphetamines
Amphetamine
(Adderall),
methamphetamine
(Desoxyn),
methylphenidate
(Ritalin),
phentermine, 4methylaminorex,
phenmetrazine
(Preludin),
methcathinone,
fenfluramine
(Pondimin, FenPhen),
dexfenfluramine
(Redux),
pseudoephedrine
(Sudafed),
ephedrine,
phenylpropanolam
ine (old
Triaminic),
phenylephrine
(Sudafed PE)
MDMA (ecstasy),
MDA, MDEA
Cocaine
Increase
release and
inhibit
reuptake of 5HT, DA, and
NE.
Euphoric,
energetic,
able to work,
concentrate,
stay awake.
Reduces
appetite.
Anxiety,
paranoia,
psychosis, high
blood pressure,
heart attack,
stroke, brain
damage when
used excessively
ADHD,
narcolepsy,
obesity, rarely
depression
Like above,
but releases a
lot more 5-HT
Euphoric,
energetic,
deep and
unusual
thoughts,
perceived
inspiration
and novelty,
enhances
sex, dancing,
music, art,
touch and
senses.
Contentment
. Connection
to other
people,
strong
emotions.
Same as
amphetamin
e (above)
Same as
amphetamine,
plus brain
damage,
confusion,
agitation,
frequently death
due to
hyperthermia,
heart attack,
water
intoxication,
and other
problems.
None
Same as
amphetamine,
plus a worse
risk of heart
attack
Local anesthesia
and bleeding
control,
diagnostic tests
Inhibits 5-HT,
NE, and DA
reuptake,
blocks
voltage-gated
sodium
S
t
i
m
u
l
a
n
t
s
channels
Narcotics
Partial, selective, or
mixed opioid
agonists
Morphine, heroin
(diacetylmorphine
), hydrocodone
(Vicodin),
oxycodone
(Percocet,
Oxycontin),
fentanyl,
Demerol, codeine,
opium,
hydromorphone
(Dilaudid),
oxymorphone
(Opana),
methadone
Buprenorphine
(Suboxone),
pentazocine,
nalbuphine,
tramadol
(Ultram),
tifluadom
Cannabis
Activate all
opioid
receptors
completely.
Reduce NE
release.
Euphoric,
pain relief,
calm,
relaxed,
sleepy,
appetite
suppression
Nausea,
constipation,
vomiting,
drowsiness,
breathing
suppressed
Pain relief,
rarely
depression and
diarrhea
Only activate
certain
subtypes of
opioid
receptors,
and/or do not
activate them
fully, and/or
block certain
subtypes.
Agonist at
cannabinoid
receptors
Pain relief,
not quite as
euphoric or
relaxing as
full agonists
(above)
Nausea,
constipation,
vomiting,
drowsiness
Pain relief,
rarely
depression,
opioid addiction
Unusual
thoughts and
feelings,
sometimes
calm, happy,
hungry,
enhanced
appreciation
of art
Memory,
thinking,
reflexes, and
coordination are
impaired. May
contribute to
psychosis in the
long term.
Might relieve
nausea,
vomiting, and
neuropathic
pain. Pills
already legal,
other forms
under
investigation.
Unknown,
probably
multiple
mechanisms
Nitrous oxide
Unknown, but
opioid
pathways are
necessary
Inhalants
Nitrites
Isoamyl nitrite,
isobutyl nitrite
Nicotine (tobacco)
DIAGNOSIS
Nicotinic
acetylcholine
receptor
agonist
Adenosine
receptor
antagonist,
inhibits some
PDE enzymes
causing
increased
cAMP
signaling
Other
Stimulate NO
system (NO is
a
neurotransmitt
er)
Calm,
relaxed,
euphoric,
pain relief,
hallucination
s, strange
sensations
(different
inhalants
cause
different
effects from
this list)
Calm,
euphoric,
pain relief,
memory
loss,
unconscious
ness
"Head rush",
muscle
relaxation,
dizziness
Many diseases,
death, nausea,
vomiting,
accidental
asphyxiation,
falls, varies
depending on
particular drug
General
anesthesia
Similar to above
General or
partial
anesthesia
Dangerously
low blood
pressure,
fainting
Heart conditions
Alertness,
wakefullness
, energy,
appetite
suppression,
headache
relief
Insomnia,
anxiety,
headaches on
withdrawal,
diuresis
Check for cognitive function. A patient may not interact with you
o Does the patient have signicant cognitive impairment?
o Is there a medical cause?
Headaches
depression?
How to assess for psychosis?
o Find out if the person is sufferening from psychosis?
o If so what is the cause of psychosis?( could be psychiatric
o
o
INTERDISCIPLINARY TEAM
Most Pyschiatric disorders are seen ad managed iun the general practise, the
Many patients with medical conditions have psychiatric disorders, e.g medical
conditions such as cushing syndrome and hyperthyroidism
STIGMA
Stigma differs from discrimination. Discrimination is unfair treatment due to a
persons identity, which includes race, ancestry, place of origin, colour, ethnic origin,
citizenship, creed, sex, sexual orientation, gender identity, gender expression, age,
marital status, family status or disability, including mental disorder. Acts of
discrimination can be overt or take the form of systemic (covert) discrimination.
Under the Ontario Human Rights Code, every person has a right to equal treatment
with respect to services, goods and facilities, without discrimination due to the
identities listed above.
Stigma is the negative stereotype and discrimination is the behaviour that results
from this negative stereotype. Often, individuals with a mental illness are faced with
multiple, intersecting layers of discrimination as a result of their mental illness and
their identity. For example, a woman with a mental illness may experience
discrimination due to sexism as well as her illness, and a racialized individual may
experience discrimination due to racism in addition to their mental illness. In
addition, living with discrimination can have a negative impact on mental health.
MEDIA
Many studies have found that media and the entertainment industry play a key role
in shaping public opinions about mental health and illness. People with mental
health conditions are often depicted as dangerous, violent and unpredictable. News
stories that sensationalize violent acts by a person with a mental health condition
are typically featured as headline news; while there are fewer articles that feature
stories of recovery or positive news concerning similar individuals. Entertainment
frequently features negative images and stereotypes about mental health conditions,
and these portrayals have been strongly linked to the development of fears and
misunderstanding.
IMPACT
WHAT
Use the STOP criteria to recognize attitudes and actions that support the stigma of
mental health conditions. Its easy, just ask yourself if what you hear:
Stereotypes people with mental health conditions (that is, assumes they are
all alike rather than individuals)?
NOTES
FROM
Synthesis and
PREVIOUS SESSION
Distribution
Receptors
Clinical
removal
Acetylcholine (Ach)
Link reaction to
produce acetyl
CoA which binds
to Choline via
acetyl
transferase,
packaged into
vesicles and
exocytosed.
Broken down by
acytylcholinester
ase
Glutamate
Converted from
glucose via
krebs cycle, then
converted to
glutamine in glial
cells, glutamine
synthetase, GLN
to GLU via
glutaminase
Significance
Basal
Forebrain
supply
neocortex,
hippocampus
, amygdala
Dorsolateral
tegmentum
of pons
basal
ganglia,
hypothalamu
s
Widespread,
most
abundant NT
in CNS.
4 tracks
corticospinal,
Corticostriate
,
hippocampus
, primary
afferents
mACh- g
protein
coupled,
more
widespread,
found on
smooth
muscle and
glands of
parasympat
hetic glands
Basal
Forebrain
learning and
memory
limbic system,
dementia and
alzheimers
NMDA Nmethyl-DAspartate
Ketamine and
ecstasy block
NMDA,
affecting short
term memory
Dorsolateral
sleep-wake
cycle,
promotes REM
nACh
in sleep cycle,
ionotropic,
controls
gangli at
electrical
neuromusc rhythms of the
ular junction hippocampus
and modulates
its functions
Kainate
AMPA
aminomethylisoxa
zole.
mGlu
Degeneration
of neurones in
anterior horn
cells can lead
to ALS
GABA
Synthesised
from glutamate
by glutamate
decarboxylase in
order to cross
the BBB
Major
inhibitoy
GABAa
ionotropic
Target for
drugs
Hyperpolaris
es axons
GABAb metabotropi
c
Inhibitory in
spinal
column,
retina and
grey matter
Ionotropic
Tetanus toxin
prevents
release of
glycine from
inhibitory
neurons,
muscular
spasm
Alpha and
beta
Norad does
not act on
beta 2
Times of
stress,
increased
cortisol,
increased
transmission of
norad in locus
coeruleus
affecting the
amygdala
affecting the
hypothalamus,
temperature,
feeding, sleep
and the limbic
system, mood
etc and the
cerebral cortex
Removed by
reuptake (see
glutamate)
Also converted
into succinate
and feeds into
krebs cycle
Glycine
See glutamate
Noradrenaline
Catecholamine
synthesis, see
lecture diagram
Removal
actively re
uptaken
Degradation MAO and COMT
Cerulean
nucleus on
floor of
4th ventricle
PNS NMJ
of
sympathetic
ANS
G-protein
Gated
Adren
aline
Upper part of
medulla
oblongata
due to
location of
phentolamine
nmethyltransfe
rase enzyme
Dopa
mine
Major
transmitter in
connections
between
basoganglia
D1
excitatory
D2 inhibits
cAMP
Parkinsons,
schizophrenia,
effects of
antipsychotic
medication
Found in
pathways
affecting the
limbic system
Produced in
substia nagra
and VTA
Serato
nin
See lecture
diagram
Raphe Nuclei
project into
the cerebral
cortex and
spinal cord
Caudal
system
Depression
3 Core
Anhedonia
Vegetative
behaviour
Atypical
antipsychotics
Serotonin
works on all
Pineal gland,
but 5HT3,
ligand gated implicated in
ion channel circadian
rhythm
2 and 4
excitatory,
the rest
inhibitory
Low mood
Anergia
6 Associated
Reduced concentration
Pessimistic
Not eating/sleeping
Other symptoms
Loss of libido
Diurnal variation
Psychomotor agitation
Under activity of monoamine transmitters eg. serotonin,
theory based on drug action
Autoreceptor sensitivity theory, inhibit uptake of
transmitter, has negative feedback of production
SSRIs, blocks transport proteins, and reduces the
number of receptors, increasing the firing rate of the neuron
Cushings syndrome, decreased serotonin increased
cortisol hippocampal damage severe depression
Brain derived neutrophic factor
Risk factors
Chronic illness
Bereavement
Stress
Hypothyroidism
Mindfulness
SSRIs
Prozac fluoxetine
Citalopram
SNRIs
TCAs
MAOI
Dizziness
Phenelezine